Latest filing published 29 Dec 2025 for Altimmune, Inc., €1,701.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Diane Jorkasky: trading record in brief
All filings by Diane Jorkasky on record concern Altimmune, Inc., in the capacity of board member. Over a trading history stretching from 27 June 2022 to 29 December 2025, the count stands at 3 filings.
In open-market terms, that means 1 purchase worth €1,701 on one side and 1 sale worth €196k on the other. The net balance comes to €194k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 option exercise. In 2025 alone, the filings show 1 purchase and no sales.
The newest entry dates from 29 December 2025: an open-market purchase of €1,701, in Altimmune, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Diane Jorkasky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 527 shares@ US$3.800.7% of flowCommon Stock, par value $0.0001SEC:0001527204-25-000005:0Canonical exit: 29 Mar 2026 (T+90)
- 17,610 shares@ US$3.150.0095% mcap100.0% of flowCommon Stock, par value $0.0001SEC:0001104659-22-075223:0
- 17,610 shares@ US$11.751578.9% of flowCommon Stock, par value $0.0001SEC:0001104659-22-075223:1
3 of 3 declarations
